Fospropofol + Propofol/Lidocaine
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Complication of Injection
Conditions
Complication of Injection, Pain
Trial Timeline
Aug 1, 2010 → Jan 1, 2013
NCT ID
NCT01401049About Fospropofol + Propofol/Lidocaine
Fospropofol + Propofol/Lidocaine is a approved stage product being developed by Eisai for Complication of Injection. The current trial status is completed. This product is registered under clinical trial identifier NCT01401049. Target conditions include Complication of Injection, Pain.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01401049 | Approved | Completed |
Competing Products
20 competing products in Complication of Injection